RE: Lisa Email2 Feb 2026 20:01
Or anyone who gets excited by that and doesn’t have access, below is the full article! I guess it does get featured, as it is there.
Of the 49 companies included in the HHI, only 19 recorded an increase in their
share prices during 2025; three companies were flat over the year and the remaining
27 decreased.
Compared with the movement in the index, 13 companies outperformed and 36
underperformed.
At 509%, the variance between the best- and worst-performing stocks was extremely
high compared to historical data, – ImmuPharma (IMM) rising 412% and Futura
Medical (FUM) down 96%; the median share price change was -8%. This excludes the
two companies that went into administration.
Given the large portfolio of constituent companies, we usually focus on both the
top five (outperformers) and the bottom five (underperformers), and try to offer a
short explanation as to why the shares performed in the way that they did.